EVALUATION OF ANTIBACTERIAL ACTIVITY OF NICKEL OXIDE NANOPARTICLES AGAINST ESCHERICHIA COLI
The study's goals are to use pyocyanin pigment produced by the clinical isolate Pseudomonas aeruginosa as a reducing and stabilizing agent for nickel oxide nanoparticles (NiO NPs) and their use it antibacterial agents against biofilm-producing, multidrug-resistant Escherichia coli isolated fro...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Baghdad University
2025-02-01
|
| Series: | The Iraqi Journal of Agricultural science |
| Subjects: | |
| Online Access: | https://www.jcoagri.uobaghdad.edu.iq/index.php/intro/article/view/2164 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The study's goals are to use pyocyanin pigment produced by the clinical isolate Pseudomonas aeruginosa as a reducing and stabilizing agent for nickel oxide nanoparticles (NiO NPs) and their use it antibacterial agents against biofilm-producing, multidrug-resistant Escherichia coli isolated from various clinical sources. The antibiotic susceptibility test of E. Coli isolates was shown to be resistant to ceftriaxone, cotrimoxazole, piperacillin-triazole, tetracycline, and ticarcillin, while sensitive to Amikacin, Amoxicillin, Nitrofurantoin, and Imipenem. NiO NPs are synthesized by using nickel sulfate NiSO4 (10g) with a concentration of pyocyanin (10mg/10ml). The NiO NPs synthesized were characterized by various techniques such as AFM, UV-VIS, and FTIR. The result showed that the wavelength of NiO was 211nm and the average diameter of NiO was 63.59 nm, and the concentration of NiO NPs was 0.5 mg/ml, showing that the maximum inhibition zones of E.coli were 22 mm. Biosynthesis of NiO NPs using pyocyanin was shown to have promising activity as an antibacterial against the biofilm-producing E. coli.
|
|---|---|
| ISSN: | 0075-0530 2410-0862 |